# A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

> clinical trial · VERIFIED · 2026-08-21

Status: RECRUITING · Sponsor: City of Hope Medical Center · Condition: Type 1 Diabetes

- Company: City of Hope Medical Center
- Sector: therapeutics
- Primary source: https://clinicaltrials.gov/study/NCT07061574

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.